🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and E...
Status
Unknown
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01926834
Treatments Being Tested
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
The study aims at: 1. Perform a multilayer analysis relying on tight integ...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-02-29
Trial ID
NCT05941234
Treatments Being Tested
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
RATIONALE: Prospective trials using hemi-ablation with high intensity focus...
Status
Recruiting
Location
University College London
Start Date
2011-06-29
Trial ID
NCT01194648
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested